- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
59 Lung Disease Trials Near You
Power is an online platform that helps thousands of Lung Disease patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerInhaled Treprostinil for Pulmonary Fibrosis
Trial Details
Key Eligibility Criteria
792 Participants Needed
BI 1015550 for Interstitial Lung Disease
Trial Details
Key Eligibility Criteria
1178 Participants Needed
Sildenafil for Bronchopulmonary Dysplasia
Trial Details
Key Eligibility Criteria
120 Participants Needed
Ralinepag for Pulmonary Arterial Hypertension
Trial Details
Key Eligibility Criteria
1000 Participants Needed
Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
Trial Details
Key Eligibility Criteria
576 Participants Needed
Inhaled Treprostinil for Pulmonary Fibrosis
Trial Details
Key Eligibility Criteria
698 Participants Needed
Inspiratory Muscle Training for Lung Transplant Recovery
Trial Details
Key Eligibility Criteria
90 Participants Needed
Alterra Prestent + SAPIEN 3 Valve for Heart Disease
Trial Details
Key Eligibility Criteria
86 Participants Needed
Ralinepag for Pulmonary Arterial Hypertension
Trial Details
Key Eligibility Criteria
1000 Participants Needed
Itepekimab for COPD
Trial Details
Key Eligibility Criteria
1239 Participants Needed
Benralizumab for COPD
Trial Details
Key Eligibility Criteria
689 Participants Needed
Dexpramipexole for COPD
Trial Details
Key Eligibility Criteria
30 Participants Needed
OHB-607 for Bronchopulmonary Dysplasia
Trial Details
Key Eligibility Criteria
338 Participants Needed
Tanimilast Add-On Therapy for COPD
Trial Details
Key Eligibility Criteria
3980 Participants Needed
Roflumilast vs Azithromycin for COPD Exacerbations
Trial Details
Key Eligibility Criteria
1250 Participants Needed
Aria CV System for Pulmonary Arterial Hypertension
Trial Details
Key Eligibility Criteria
30 Participants Needed
Zipalertinib for Non-Small Cell Lung Cancer
Trial Details
Key Eligibility Criteria
220 Participants Needed
BMS-986278 for Pulmonary Fibrosis
Trial Details
Key Eligibility Criteria
1092 Participants Needed
Autologous LN-145 for Lung Cancer
Trial Details
Key Eligibility Criteria
170 Participants Needed
Ibuzatrelvir for Coronavirus
Trial Details
Key Eligibility Criteria
2330 Participants Needed
Why Other Patients Applied
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."
Trial Details
Key Eligibility Criteria
1016 Participants Needed
Repotrectinib for Solid Tumors
Trial Details
Key Eligibility Criteria
500 Participants Needed
Multiple Treatments for Pneumonia
Trial Details
Key Eligibility Criteria
20000 Participants Needed
Tozorakimab for Viral Pneumonia
Trial Details
Key Eligibility Criteria
2870 Participants Needed
Selpercatinib for Solid Tumors
Trial Details
Key Eligibility Criteria
857 Participants Needed
Trial Details
Key Eligibility Criteria
200 Participants Needed
Chemotherapy +/− Ganitumab for Ewing Sarcoma
Trial Details
Key Eligibility Criteria
312 Participants Needed
STAR0602 for Advanced Cancers
Trial Details
Key Eligibility Criteria
365 Participants Needed
Tabelecleucel for Post-Transplant Cancer
Trial Details
Key Eligibility Criteria
66 Participants Needed
MAGE-A4ᶜ¹º³²T Therapy for Cancer
Trial Details
Key Eligibility Criteria
71 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Lung Disease clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Lung Disease clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Lung Disease trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Lung Disease is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Lung Disease medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Lung Disease clinical trials?
Most recently, we added Tezepelumab for COPD, Ibuzatrelvir for Coronavirus and Vimseltinib for Chronic Graft-Versus-Host Disease to the Power online platform.